2017 Fiscal Year Final Research Report
Study of gene amplification and metastasis in melanoma
| Project/Area Number |
26461700
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Dermatology
|
|---|
| Research Institution | Saitama Medical University (2016-2017)
Takasaki University of Health and Welfare (2014-2015) |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
斎藤 克代 高崎健康福祉大学, 薬学部, 助手 (90455288)
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
SATO Atsuko 自治医科大学, 医学部, 助教 (50382916)
|
|---|
| Research Collaborator |
HORIUCHI Yutaka 埼玉医科大学, 医学部, 講師 (30608906)
|
|---|
| Project Period (FY) |
2014-04-01 – 2018-03-31
|
| Keywords | がん / メラノーマ / 遺伝子機能 / 上皮間葉転換 / 細胞運動 |
|---|
| Outline of Final Research Achievements |
We developed a luciferase-based luminescent assay system to evaluate cell migration using transformed NIH3T3 cells, and the assay system allowed to screen chemicals to inhibit cell migration. Subsequently, the mevalonate pathway appeared critical for migration in cancerous cells, including melanoma. Furthermore, we examined an amplified gene expression pattern using human melanoma cell lines that xenogeneically metastasized to the brain of NOD/SCID mice. Data suggested that 99 candidate genes were highly expressed in progressed melanoma. Further in silico analysis also suggested that some of candidate genes are associated in the biology of melanoma. Perhaps, the function of these candidate genes may be implicated in melanoma-specific tumor progression and its therapeutic resistance.
|
| Free Research Field |
皮膚腫瘍学
|
